Managers / Q3 2022 · view latest →
EQUITEC PROPRIETARY MARKETS, LLC
CIK 0001143261 · 111 W. JACKSON, 20TH FL.OOR, CHICAGO, IL, 60604 · 312 692-5009
Summary
Equitec Proprietary Markets, LLC reported $380M in U.S.-listed holdings across 292 positions for Q3 2022.
Its largest position, RILY, represents 14.9% of the portfolio.
Compared with Q2 2022, the fund opened 50 new positions and exited 66.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.7% · $234M
- Other · 24.8% · $94M
- ETP · 7.4% · $28M
- REIT · 2.8% · $11M
- Equity WRT · 1.9% · $7M
- Other · 1.3% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L | NEW | +298.1K | 298.1K | +$45M | $45M |
| SPDR S&P 500 ETF TR | NEW | +76.3K | 76.3K | +$27M | $27M |
| GBTUSDGLOBAL BLOOD THERAPEUTICS IN | NEW | +83.7K | 83.7K | +$6M | $6M |
| 1LIFE HEALTHCARE INC | NEW | +95.2K | 95.2K | +$2M | $2M |
| TRQCADTURQUOISE HILL RES LTD | NEW | +52.4K | 52.4K | +$2M | $2M |
| RFPUSDRESOLUTE FST PRODS INC | NEW | +37.9K | 37.9K | +$758,000 | $758,000 |
| COHRCOHERENT CORP | NEW | +18.2K | 18.2K | +$635,000 | $635,000 |
| FORMA THERAPEUTICS HLDGS INC | NEW | +21.7K | 21.7K | +$434,000 | $434,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $187M | 81 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 84 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $440M | 77 | Nov 26, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $106M | 65 | Aug 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $141M | 66 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $102M | 72 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $117M | 73 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $79M | 80 | Jul 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $164M | 90 | Apr 26, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2023 | $135M | 109 | Jan 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $405M | 132 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $331M | 106 | Jul 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $212M | 162 | Apr 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $315M | 213 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $380M | 292 | Oct 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $353M | 300 | Jul 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $457M | 265 | Apr 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $739M | 441 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $540M | 274 | Oct 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $334M | 304 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $318M | 321 | Apr 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $384M | 128 | Jan 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $131M | 99 | Oct 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $257M | 58 | Jan 30, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.